These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 5795033)

  • 1. Effect of intravenous tolbutamide on serum insulin levels in pancreatic diabetes.
    Joffe BI; Bank S; Jackson WP; Vinik AI; Keller P
    Diabetes; 1969 Jul; 18(7):499-501. PubMed ID: 5795033
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin response to glucose and tolbutamide in "essential" versus "pancreatic" mild glucose intolerance.
    Vague P; Ramahandridona G; Gerolami A
    Diabetes; 1974 Nov; 23(11):896-901. PubMed ID: 4430416
    [No Abstract]   [Full Text] [Related]  

  • 3. Insulin response to glucose, tolbutamide, secretin, and isoprenaline in maturity-onset diabetes mellitus.
    Deckert T; Lauridsen UB; Madsen SN; Mogensen P
    Dan Med Bull; 1972 Oct; 19(7):222-6. PubMed ID: 5079926
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic studies in diabetics on tolbutamide. Comparison of a single dose with a divided dose regimen.
    Vinik AI; Jackson WP; Keller P; Marine N
    Diabetologia; 1968 Aug; 4(4):203-9. PubMed ID: 5738360
    [No Abstract]   [Full Text] [Related]  

  • 5. Response of blood sugar, pyruvate and serum ILA (rat hemidiaphragm) to intravenous sodium tolbutamide in normal and diabetic subjects.
    Rastogi GK
    Indian J Med Res; 1970 Apr; 58(4):438-43. PubMed ID: 5506667
    [No Abstract]   [Full Text] [Related]  

  • 6. An evaluation of secondary failure to tolbutamide therapy.
    Jerums G; Ennis GC; Miller M
    Aust N Z J Med; 1974 Oct; 4(5):467-74. PubMed ID: 4616676
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of a rapid intravenous injection of glucose or tolbutamide on plasma-insulin concentration in normal and diabetic subjects.
    Schreuder HB; Schopman W
    Acta Physiol Pharmacol Neerl; 1967 Dec; 14(4):523. PubMed ID: 5582727
    [No Abstract]   [Full Text] [Related]  

  • 8. Insulin reserve in patients with chronic pancreatitis.
    Joffe BI; Bank S; Jackson WP; Keller P; O'Reilly IG; Vinik AI
    Lancet; 1968 Oct; 2(7574):890-2. PubMed ID: 4176149
    [No Abstract]   [Full Text] [Related]  

  • 9. [Serum immunoreactive insulin after the oral administration of single dose of tolbutamide. I. Peripheral vein immunoreactive insulin in normal subjects and mild diabetics (author's transl)].
    Goto A
    Nihon Naibunpi Gakkai Zasshi; 1975 Aug; 51(8):676-84. PubMed ID: 1237421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-response relationships of tolbutamide and glibenclamide in diabetes mellitus.
    Heine P; Kewitz H; Schnapperelle U
    Eur J Clin Pharmacol; 1974 Aug; 7(5):321-30. PubMed ID: 4213593
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunoreactive insulin in the portal and the peripheral venous blood after intravenous tolbutamide administration.
    Erwald R; Hed R; Nygren A; Röjdmark S; Sundblad L; Wiechel KL
    Diabetes; 1971 Oct; 20(10):686-90. PubMed ID: 5110700
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma-insulin after tolbutamide in diabetics and non-diabetics.
    Deckert T; Mogensen P
    Acta Med Scand; 1970 Apr; 187(4):309-12. PubMed ID: 5447096
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative studies of the oral and intravenous tolbutamide test. II. Determination of glucose, serum-insulin and serum-tolbutamide in normal young subjects].
    Berchtold P; Büber V; Meier V; Felber JP; Keiser G
    Diabetologia; 1971 Apr; 7(2):77-81. PubMed ID: 5581543
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum immunoreactive insulin level and tolbutamide concentration in the peripheral blood after a single oral dose of tolbutamide in man.
    Kawanishi K; Goto A; Ishida T
    Acta Med Okayama; 1973 Dec; 27(5):177-83. PubMed ID: 4273584
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of long-term tolbutamide treatment on glucose tolerance and insulin secretion in maturity-onset diabetes without obesity.
    Lauvaux JP; Mandart G; Heymans G; Ooms HA
    Horm Metab Res; 1972 Mar; 4(2):58-62. PubMed ID: 5028221
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of tolbutamide on plasma catecholamine in insulin dependent diabetics.
    Sato T; Miura Y; Saito T; Ito M; Kokubun M; Sakuma H; Adachi M; Yoshinaga K
    Tohoku J Exp Med; 1979 Jan; 127(1):97-8. PubMed ID: 760255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous tolbutamide adminisration in the control of diabetes during operation.
    Schmitt H; Liebermeister H; Lo Sardo G; Daweke H
    Ger Med Mon; 1969 Sep; 14(9):444-9. PubMed ID: 5352296
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of short-term tolbutamide treatment on insulin dynamics in newly diagnosed obese and non-obese adult diabetics.
    Wajchenberg BL; Nakasone K; Pasternak K
    Horm Metab Res; 1970 Jan; 2(1):6-8. PubMed ID: 5520756
    [No Abstract]   [Full Text] [Related]  

  • 19. Can diet be responsible for the initial lesion in diabetes?
    Wapnick S; Wicks AC; Kanengoni E; Jones JJ
    Lancet; 1972 Aug; 2(7772):300-2. PubMed ID: 4115032
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diminution of delay in insulin secretion in early diabetes mellitus with ongoing tolbutamide treatment].
    Nadeau A; Catellier C
    Union Med Can; 1974 Mar; 103(3):413-7. PubMed ID: 4820869
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.